APA (7th ed.) Citation

Yan, J., Yang, X., Lu, J., Wu, S., Wang, Y., Du, Y., . . . Li, Y. (2025). Development of a circadian-related prognostic signature highlights RBM17 as a stemness regulator in liver cancer. Cancer Cell International, 25(1), 1. https://doi.org/10.1186/s12935-025-03843-6

Chicago Style (17th ed.) Citation

Yan, Jingsong, et al. "Development of a Circadian-related Prognostic Signature Highlights RBM17 as a Stemness Regulator in Liver Cancer." Cancer Cell International 25, no. 1 (2025): 1. https://doi.org/10.1186/s12935-025-03843-6.

MLA (9th ed.) Citation

Yan, Jingsong, et al. "Development of a Circadian-related Prognostic Signature Highlights RBM17 as a Stemness Regulator in Liver Cancer." Cancer Cell International, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12935-025-03843-6.